QuantumCTek(688027)
Search documents
8月12日晚间公告 | 衢州发展拟购买先导电子;臻镭科技中报净利润增逾10倍
Xuan Gu Bao· 2025-08-12 12:02
Group 1: Resumption of Trading - Jin Chengzi plans to acquire 55% stake in Samit and will resume trading tomorrow; Samit specializes in high-precision fast-reflecting mirror business [1] - Quzhou Development intends to purchase 95.4559% of Xian Dao Electronics and will resume trading tomorrow; Xian Dao focuses on the R&D of sputtering targets and evaporation materials for vacuum coating [1] Group 2: Mergers, Acquisitions, and Capital Increases - China Shipbuilding's dissenting shareholders' acquisition request price is set at 30.02 yuan per share [2] - Jiangsu Suopu plans to raise no more than 1.5 billion yuan through a private placement for the ethylene acetate and EVA integration project (Phase I) [3] - Guangli Microelectronics is acquiring 100% of LUCEDA NV to strategically position itself in silicon photonics technology [4] Group 3: Share Buybacks, Increases, and Equity Transfers - Zhenlei Technology has raised its share buyback price from 38.13 yuan per share to 74 yuan per share [5] - Fuanna has conducted its first buyback of 1 million shares [6] - Shaanxi Jinye plans to repurchase shares worth between 40 million and 70 million yuan, with loans not exceeding 63 million yuan [7] - Donghua Energy's controlling shareholder's concerted action party has received a commitment letter for a special loan to increase holdings, not exceeding 225 million yuan [8] - Taimusi's controlling shareholder intends to transfer 29.99% of the company's shares, with Guangzhou State-owned Assets Supervision and Administration Commission becoming the actual controller [9] Group 4: External Investments and Daily Operations - Haikang obtained the clinical trial approval notice for the innovative drug HSK47977 tablets [10] - Rundou Co., Ltd. received approval for the listing application of glucosamine sulfate sodium chloride compound as a chemical raw material drug [11] - Beilu Pharmaceutical's subsidiary Haichang Pharmaceutical's iodine mepivacaine chemical raw material drug has been approved for listing [12] - Baiyun Airport signed a cooperation contract with China Duty Free Group for the operation of the T3 terminal's outbound duty-free project [13] - Guoshield Quantum plans to sign a sales contract worth 76.5418 million yuan with China Telecom Quantum Group for the sale of quantum key distribution hardware and software [14] Group 5: Performance Changes - Zhenlei Technology's net profit for the first half of 2025 is 62.3197 million yuan, a year-on-year increase of 1006.99%; the company continues to strengthen its advantages in special fields such as data links, electronic countermeasures, wireless communication terminals, next-generation radios, and phased array communications, achieving significant growth in orders and projects [15] - Jingchen Co., Ltd. reported a net profit of 497 million yuan for the first half of the year, a year-on-year increase of 37.12% [16] - China Unicom's net profit for the first half of 2025 is 6.349 billion yuan, a year-on-year increase of 5.1% [17] - Shuanghui Development's net profit for the first half of the year is 2.323 billion yuan, a year-on-year increase of 1.17%; the company plans to distribute 6.5 yuan per 10 shares [18] - Jinlongyu's net profit for the first half of the year is 1.756 billion yuan, a year-on-year increase of 60.07% [19]
国盾量子(688027.SH)发布半年度业绩,归母净亏损2379万元
智通财经网· 2025-08-12 11:16
Core Insights - Guodun Quantum (688027.SH) reported a revenue of 121 million yuan for the first half of 2025, representing a year-on-year increase of 74.54% [1] - The company recorded a net loss attributable to shareholders of 23.79 million yuan, with a non-deductible net profit loss of 46.75 million yuan, and basic earnings per share of -0.23 yuan [1] Revenue Growth - The significant revenue growth was driven by increases in sales from quantum computing, quantum communication, and quantum precision measurement businesses [1] - Quantum computing sales revenue surged by 283.92% year-on-year, while quantum communication and quantum precision measurement sales revenues grew by 28.10% and 13.75% respectively [1] Profitability - The total profit and net profit attributable to shareholders showed a reduction in losses compared to the previous year, primarily due to the increase in operating revenue and government subsidies recognized in the current period [1] - Basic and diluted earnings per share increased year-on-year, reflecting the reduced net loss attributable to shareholders [1]
国盾量子:上半年净亏损2379万元
Bei Ke Cai Jing· 2025-08-12 10:51
新京报贝壳财经讯 8月12日,国盾量子公告,2025年上半年营业收入1.21亿元,同比增长74.54%。归属 于上市公司股东的净亏损2379万元,上年同期净亏损3534.28万元。 编辑 王进雨 ...
国盾量子:拟与中电信量子集团签订7654.18万元销售合同 向其销售量子密钥分发软硬件设
Ge Long Hui A P P· 2025-08-12 10:42
Core Insights - The company, GuoDun Quantum (688027.SH), announced plans to sign a sales contract with China Telecom Quantum Information Technology Group Co., Ltd. to sell quantum key distribution hardware and software products for quantum metropolitan area network construction, with an expected amount of 76.5418 million yuan [1] - Additionally, the company intends to sign a service contract with China Telecom Quantum Technology Co., Ltd. to provide specialized technical services for "quantum secure communication business," with an expected amount of 14 million yuan [1] - These transactions are classified as routine related-party transactions and comply with relevant regulations, pending approval from the company's shareholders' meeting [1]
国盾量子:2025年半年度净利润约-2379万元
Mei Ri Jing Ji Xin Wen· 2025-08-12 10:31
(文章来源:每日经济新闻) 国盾量子(SH 688027,收盘价:277.6元)8月12日晚间发布半年度业绩报告称,2025年上半年营业收 入约1.21亿元,同比增加74.54%;归属于上市公司股东的净利润亏损约2379万元;基本每股收益亏损 0.23元。2024年同期营业收入约6954万元;归属于上市公司股东的净利润亏损约3534万元;基本每股收 益亏损0.44元。 ...
国盾量子(688027) - 第四届董事会第十五次会议决议公告
2025-08-12 10:30
(一)审议通过《关于<国盾量子 2025 年半年度报告>及摘要的议案》 表决情况:同意 9 票,反对 0 票,弃权 0 票。 具体内容详见公司在上海证券交易所网站(www.sse.com.cn)披露的《2025 年半 年度报告》《2025 年半年度报告摘要》。 证券代码:688027 证券简称:国盾量子 公告编号:2025-042 科大国盾量子技术股份有限公司 第四届董事会第十五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 科大国盾量子技术股份有限公司(以下简称"国盾量子"或"公司")第四届董 事会第十五次会议于 2025 年 8 月 12 日以现场及通讯方式在公司会议室召开。本次会 议由董事长吕品先生主持,本次会议应到董事 9 人,实际到会董事 9 人。本次会议的 召集、召开和表决程序符合《中华人民共和国公司法》《上海证券交易所科创板股票 上市规则》等相关法律、行政法规、规范性文件及《科大国盾量子技术股份有限公司 章程》的有关规定。会议决议合法、有效。 二、董事会会议审议情况 经与会 ...
国盾量子:8月12日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-12 10:28
国盾量子(SH 688027,收盘价:277.6元)8月12日晚间发布公告称,公司第四届第十五次董事会会议 于2025年8月12日在公司会议室召开。会议审议了《关于 <国盾量子2025年半年度报告> 及摘要的议 案》等文件。 2024年1至12月份,国盾量子的营业收入构成为:量子通信行业占比57.79%,量子计算行业占比 22.33%,量子测精密量行业占比15.32%,其他业务占比4.56%。 (文章来源:每日经济新闻) ...
国盾量子(688027) - 2025 Q2 - 季度财报
2025-08-12 10:20
科大国盾量子技术股份有限公司2025 年半年度报告 公司代码:688027 公司简称:国盾量子 科大国盾量子技术股份有限公司 2025 年半年度报告 1 / 192 科大国盾量子技术股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 二、 重大风险提示 公司已在本报告中详细阐述公司在经营过程可能面临的各种风险及应对措施,敬请查阅本报告 "第三节 管理层讨论与分析"之"四、风险因素"。 三、 公司全体董事出席董事会会议。 四、 本半年度报告未经审计。 五、 公司负责人吕品、主管会计工作负责人谭琪及会计机构负责人(会计主管人员)张小道声 明:保证半年度报告中财务报告的真实、准确、完整。 六、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 不适用 七、 是否存在公司治理特殊安排等重要事项 □适用 √不适用 八、 前瞻性陈述的风险声明 √适用 □不适用 本报告所涉及的公司未来计划、发展战略等前瞻性陈述,不构成公司对投资者的实质承诺,请投 资者注意投 ...
国盾量子(688027) - 国元证券股份有限公司关于科大国盾量子技术股份有限公司日常关联交易事项的核查意见
2025-08-12 10:17
国元证券股份有限公司 关于科大国盾量子技术股份有限公司 日常关联交易事项的核查意见 国元证券股份有限公司(以下简称"国元证券"或"保荐机构")作为科大 国盾量子技术股份有限公司(以下简称"公司"或"国盾量子")2024年度向特 定对象发行 A 股股票的保荐机构,根据《上市公司证券发行注册管理办法》《证 券发行上市保荐业务管理办法》《上海证券交易所科创板股票上市规则》《上海证 券交易所科创板上市公司自律监管指引第1号 -- 规范运作》等有关法律法规和 规范性文件的要求,对国盾量子拟发生的日常关联交易事项进行了专项核查,具 体核查情况如下: 一、关联交易概述 根据公司第四届董事会第十五次会议审议通过,公司拟与中电信量子集团签 订 1 份销售商品合同,向其销售量子密钥分发软硬件设备等相关产品,预计金额 为 7,654.18万元。包含此次交易,自此往前追溯 12个月,公司与关联方签订的 销售商品合同金额合计为 7.959.32 万元(剔除公司已对外披露的关联交易金额)。 公司拟与中电信量子科技签订1 份服务合同,向其量子密话密信业务提供专 项技术服务,预计金额为1,400万元。包含此次交易,自此往前追溯12个月, 公 ...